Implant-derived CoCrMo alloy nanoparticle disrupts DNA replication dynamics in neuronal cells

Area of Science:

• Biomaterials Science
• Orthopedic Surgery
• Toxicology

Background:

• Cobalt-chromium-molybdenum (CoCrMo) nanoparticles from hip implants present complex toxicity profiles.
• Understanding the bioactivity of implant degradation products (DPs) is crucial for patient safety.

Purpose of the Study:

• To compare the toxicity of physiologically relevant CoCrMo degradation products (DPs) versus processed degradation products (PDPs) on neuronal cells.
• To investigate the genotoxic effects and cellular responses induced by implant-generated debris.

Main Methods:

• Utilized a hip simulator to generate CoCrMo DPs under physiologically relevant conditions.
• Assessed neuronal cell toxicity, DNA damage (double- and single-stranded breaks, alkaline labile adducts), and reactive oxygen species (ROS) levels.
• Compared the effects of DPs against PDPs.

Main Results:

• DPs induced significantly higher levels of DNA damage compared to PDPs.
• DPs were found to be bioactive, unlike PDPs, and increased intracellular ROS levels in neuronal cells.
• DPs altered DNA replication dynamics, indicating a greater biological impact.

Conclusions:

• Physiologically relevant CoCrMo DPs exhibit greater cytotoxicity and genotoxicity than PDPs.
• The physicochemical properties of CoCrMo debris are critical factors in experimental design for implant-related toxicity.
• DP bioactivity must be considered in the evaluation of implant safety and patient outcomes.